News & Updates

Psilocybin eases depression, with minor impact on brain responsiveness

Treatment with psilocybin results in significant improvements in depressive symptoms, and its use only shows a minor effect on brain responsiveness to emotional stimuli.

Psilocybin eases depression, with minor impact on brain responsiveness

a day ago

Ropeginterferon α-2b extends benefit to another rare blood cancer

a day ago by

Topline results of the phase III SURPASS-ET trial show the superior efficacy of ropeginterferon α-2b (ropeg) compared with anagrelide as second-line (2L) treatment for high-risk essential thrombocythaemia (ET), a rare blood cancer that may progress to myelofibrosis or acute myeloid leukaemia.

Ropeginterferon α-2b extends benefit to another rare blood cancer

a day ago

Utidelone plus bevacizumab shows promise in ERBB2-negative MBC

a day ago

Combination treatment with utidelone plus bevacizumab has demonstrated therapeutic potential in patients with ERBB2-negative metastatic breast cancer (MBC) and active brain metastases in a single-arm, phase II study conducted in China.

Utidelone plus bevacizumab shows promise in ERBB2-negative MBC

a day ago

Undernutrition drives up hospitalizations for older Singaporeans

02 Jul 2025 by

New research points to undernutrition as a key factor contributing to increases in emergency department (ED) visits and inpatient admissions among older adults in Singapore.

Undernutrition drives up hospitalizations for older Singaporeans

02 Jul 2025

Short-course antibiotic for paediatric CAP on par with long-course regimen

02 Jul 2025

A short-course antibiotic treatment for children with community-acquired pneumonia (CAP) demonstrates effectiveness similar to the long-course regimen but with fewer serious adverse events (AEs), reports a study.

Short-course antibiotic for paediatric CAP on par with long-course regimen

02 Jul 2025

AMPLITUDE: Niraparib plus AAP improves survival in mCSPC patients with gene mutations

02 Jul 2025 by

The combination of niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) results in significant improvements in radiographic progression-free survival (rPFS) and time to symptomatic progression (TSP) in metastatic castration-sensitive prostate cancer (mCSPC) patients with alterations in homologous recombination repair (HRR) genes, as shown by the results of the phase III AMPLITUDE trial.

AMPLITUDE: Niraparib plus AAP improves survival in mCSPC patients with gene mutations

02 Jul 2025

Ceftazidime-avibactam, ceftolozane-tazobactam safe for use in children

02 Jul 2025

Treatment with either ceftazidime-avibactam (CAZ/AVI) or ceftolozane-tazobactam (C/T) is well tolerated and effective in children infected with Gram-negative pathogens resistant to carbapenems, a recent study has shown.

Ceftazidime-avibactam, ceftolozane-tazobactam safe for use in children

02 Jul 2025

Flu shot during pregnancy extends protection to offspring

02 Jul 2025

Influenza vaccination in pregnant women, especially during the second or third trimester, cuts the risk of infection in infants, as shown in a study.

Flu shot during pregnancy extends protection to offspring

02 Jul 2025

Two-drug combo rises to the challenge as 1L Tx for mTNBC

02 Jul 2025 by

In the primary analysis of the ASCENT-04/KEYNOTE-D19 study, a combination regimen comprising sacituzumab govitecan (SG) and pembrolizumab delivers significant progression-free survival (PFS) benefit in women with previously untreated PD-L1+ advanced triple-negative breast cancer (TNBC).

Two-drug combo rises to the challenge as 1L Tx for mTNBC

02 Jul 2025

Time-restricted eating helps with weight loss without harming health-related outcomes

01 Jul 2025

Incorporating time-restricted eating (TRE) into a usual care intervention appears to be a viable weight management strategy in adults with overweight or obesity, with a study showing that TRE does not adversely affect sleep, mood, or quality of life.

Time-restricted eating helps with weight loss without harming health-related outcomes

01 Jul 2025

News & Updates

Filter by Specialty:

Specialty:

Psilocybin eases depression, with minor impact on brain responsiveness

Psilocybin eases depression, with minor impact on brain responsiveness

Ropeginterferon α-2b extends benefit to another rare blood cancer

Ropeginterferon α-2b extends benefit to another rare blood cancer

Utidelone plus bevacizumab shows promise in ERBB2-negative MBC

Utidelone plus bevacizumab shows promise in ERBB2-negative MBC

Undernutrition drives up hospitalizations for older Singaporeans

Undernutrition drives up hospitalizations for older Singaporeans

Short-course antibiotic for paediatric CAP on par with long-course regimen

Short-course antibiotic for paediatric CAP on par with long-course regimen

AMPLITUDE: Niraparib plus AAP improves survival in mCSPC patients with gene mutations

AMPLITUDE: Niraparib plus AAP improves survival in mCSPC patients with gene mutations

Ceftazidime-avibactam, ceftolozane-tazobactam safe for use in children

Ceftazidime-avibactam, ceftolozane-tazobactam safe for use in children

Flu shot during pregnancy extends protection to offspring

Flu shot during pregnancy extends protection to offspring

Two-drug combo rises to the challenge as 1L Tx for mTNBC

Two-drug combo rises to the challenge as 1L Tx for mTNBC

Time-restricted eating helps with weight loss without harming health-related outcomes

Time-restricted eating helps with weight loss without harming health-related outcomes